HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC)
Clinical trials for HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) trials appear
Sign up with your email to follow new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Triple-Drug attack before surgery shows promise against tough head & neck cancer
Disease control Not yet recruitingThis study tests whether giving three drugs together before surgery can better shrink advanced head and neck tumors. About 30 adults with stage III/IVA cancer will receive the combination for 6-12 weeks, then have surgery. Researchers will check how many patients have no cancer l…
Matched conditions: HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC)
Phase: PHASE2 • Sponsor: Sir Run Run Shaw Hospital • Aim: Disease control
Last updated May 26, 2026 09:00 UTC
-
Immunotherapy plus chemo before surgery may keep head and neck cancer away longer
Disease control Not yet recruitingThis study tests two short treatments given before surgery for advanced head and neck cancer. One group gets an immunotherapy drug (toripalimab) alone, the other gets toripalimab plus two cycles of chemotherapy. After treatment, all patients have standard surgery and radiation. T…
Matched conditions: HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC)
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New PET scan could reveal how well head and neck cancer responds to therapy
Knowledge-focused Not yet recruitingThis study tests a special PET scan called [18F]-AraG to see how well it can track the immune response and treatment results in people with advanced head and neck cancer. Five adults receiving standard chemoradiotherapy will get the scan before and during treatment. The goal is t…
Matched conditions: HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC)
Phase: EARLY_PHASE1 • Sponsor: Indiana University • Aim: Knowledge-focused
Last updated May 20, 2026 11:53 UTC